COGNANOUS

Cognano is an AI-driven biotechnology company specializing in the discovery and development of VHH antibodies (nanobodies) derived from alpacas. The company leverages its proprietary IBMET (Inverse Biomarker Exploring Technology) platform and 'Structure-Omics' approach to identify novel disease-specific targets and structural biomarkers that are often invisible to traditional methods. Cognano's pipeline includes therapeutic candidates for SARS-CoV-2 and research programs in oncology, specifically targeting pancreatic cancer and triple-negative breast cancer. By integrating massive biological datasets with advanced machine learning models like VHHBERT, the company aims to accelerate the drug discovery process and provide precise diagnostic tools for unmet medical needs.